Skip to content
Press Releases
Filter Releases
 
Press Releases
Oct 5, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that data from five studies validating the performance of the next-generation Afirma® Genomic Sequencing Classifier (GSC) in thyroid cancer diagnosis will be presented at the 87th Annual Meeting of the Ameri...
PDF
Sep 25, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that the Centers for Medicare & Medicaid Services (CMS) published preliminary 2018 rates for clinical diagnostic laboratory tests. The reimbursement rate for the Afirma Genomic Classifier (code 81545) is expected...
PDF
Sep 19, 2017
SOUTH SAN FRANCISCO, Calif. and RALEIGH, N.C., Sept. 19, 2017 /PRNewswire/ -- Veracyte, Inc. today announced the launch of Screen Together (www.ScreenTogether.com), an awareness campaign aimed at increasing routine screening among the millions of Americans at high risk for lung cancer. This unique campaign, introduced locally in partnership with th...
PDF
Sep 19, 2017
- Screen Together Campaign with Lung Cancer Initiative Underscores Company's Commitment to Improving Outcomes for People at High Risk of Lung Cancer - SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that it has partnered with the ...
PDF
Sep 13, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2017 at 2:15 p.m. Eastern Time in New York, NY. ...
PDF
Aug 24, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the Morgan Stanley 15th Annual Global Healthcare Conference on Monday, September 11, 2017 at 5:25 p.m. Eastern Time in New York, NY. ...
PDF
Jul 31, 2017
Reports 25% Revenue Growth, to $18.4 Million, and 37% Improvement in Loss from Operations Over Prior Year Conference Call and Webcast Today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the ...
PDF
Jul 31, 2017
Enhanced Classifier Identifies 30% More Benign Patients Than Original, Flagship Test SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced today that an oral presentation of data from the pivotal clinical validation study of the Afirma Genomic ...
PDF
Jul 26, 2017
-- Oral Presentation Highlights Next-Generation Afirma Genomic Sequencing Classifier -- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that an oral presentation of data from the pivotal clinical validation study of the company's ...
PDF
Jul 18, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced today that it will report its second quarter 2017 financial results after the close of market on Monday, July 31, 2017. Following the announcement, Veracyte's management will host a live conference call and webcast at ...
PDF
Page: First Previous
...
Next Last